StemCells Inc Share Price Nasdaq
Equities
US85857R2040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.37Cr 113.95Cr |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.32% |
Managers | Title | Age | Since |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 02/88/02 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 01/22/01 |
Chief Tech/Sci/R&D Officer | - | 01/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 28/16/28 |
Director/Board Member | 66 | 12/17/12 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 01/20/01 |
1st Jan change | Capi. | |
---|---|---|
+29.59% | 4.92TCr | |
+0.94% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.59% | 2.61TCr | |
-22.71% | 1.87TCr | |
+8.37% | 1.33TCr | |
+32.23% | 1.23TCr | |
-0.96% | 1.2TCr |